炎症性肠病:新兴疗法和未来治疗策略
Elisabetta Bretto1,2, Davide Giuseppe Ribaldone1,2, Gian Paolo Caviglia1
1Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
炎症性肠病 (IBD) 的新兴疗法在早期试验中显示出前景,解决了改善克罗恩氏病治疗的新机制.
科学领域:
- 胃肠道学和免疫学
- 药物的发现和开发.
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),是一种慢性疾病,全球发病率不断增加.
- 目前的生物疗法改善了IBD管理,但存在局限性,包括不良事件和对某些患者的效果不足.
- IBD的确切原因尚不清楚,尽管遗传,环境和免疫学因素都与此有关.
研究的目的:
- 审查IBD新型治疗药物的临床试验数据.
- 突出针对特定病原体机制的新兴疗法.
- 讨论这些新疗法对未来IBD护理的潜在影响.
主要方法:
- 对新的IBD药物早期临床试验数据的审查.
- 分析新兴疗法,包括JAK抑制剂,抗IL-23抗体,S1P受体调节剂和抗整蛋白疗法.
- 专注于正在进行的研究中的疗效和安全数据.
主要成果:
- 针对新途径的新兴疗法在初步临床研究中显示出有前途的疗效和安全性.
- 审查的特定药物包括选择性JAK抑制剂,抗IL-23抗体,斯芬戈辛-1-酸盐受体调节剂和抗整蛋白疗法.
- 这些新疗法为那些对现有疗法反应不足或不耐受的患者提供了潜在的替代方案.
结论:
- 新的治疗策略正在推动炎症性肠道疾病的治疗格局.
- 针对特定疾病机制的新兴药物具有改善患者结果的巨大潜力.
- 持续的研究和临床试验对于实现这些创新药物的全部治疗潜力至关重要.
更多相关视频
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Ulcerative Colitis in IBD
